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REM sleep behavior disorder
(RBD)
Update on diagnosis and treatment
Background
The International Classiﬁcation of Sleep
Disorders (ICSD-3) [1] states the fol-
lowing diagnostic criteria for REM
sleep behavior disorder (RBD): (1) Re-
peated episodes of sleep-related vocal-
ization and/or complexmotor behaviors.
(2) These behaviors are documented by
polysomnography to occur during REM
sleep or, based on clinical history of
dream enactment, are presumed to oc-
cur during REM sleep. (3) Polysomno-
graphic recording demonstrates REM
sleep without atonia (RWA). (4) The
disturbance is not better explained by
another sleep disorder, mental disorder,
medication or substance abuse.
These criteria ensure thatdeﬁnitivedi-
agnosisofRBDaccordingtothe ICSDcan
only bemade on the basis of polysomno-
graphy (PSG). Exactly how RBD is diag-
nosed using PSG will be discussed later.
Thisreviewarticlepresents thecurrent
knowledge pertaining to diagnosis and
treatment of RBD.
Clinical picture
The prevalence of RBD is reported to be
0.38–2.1 % [2, 3] in the general popula-
tion. Prevalence rates are higher among
patients with Parkinson’s disease (PD)
or other synucleinopathies: 51% among
patients with de novo PD [4] and up to
88% among patients with multiple sys-
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tem atrophy (MSA) [5–8] and various
other diseases [9].
Particularly characteristic of RBD is
that patients enact their dreams using
movements and vocalizations. This often
gives patients’ bed partners the impres-
sion that they know what is happening
in the dream, for example if the patient
is trying to chase away a dog by kicking
their feet and cursing loudly. Also char-
acteristic is that the RBD episodes, which
are associated with REM sleep, normally
arise after midnight and generally do not
occur during the ﬁrst hour after falling
asleep. If patients are woken during an
RBDepisode, they can often report on an
elaborate dream. Patients are generally
easy to wake and quick to reorient them-
selves. One further characteristic is that
the behavior exhibited during an RBD
episode is highly variable, even when the
same patients are considered.
Screening methods
Since polysomnographic evaluation is
not universally available and diagnos-
ing RBD requires speciﬁc qualiﬁcations,
numerous questionnaires have been de-
veloped to screen forRBD. It is important
to note that questionnaires only enable
diagnosis of probable RBD.
The ﬁrst and most frequently applied
questionnaire was devised by Karin Sti-
asny-Kolster and published in 2007 [10].
This questionnaire comprises 10 items,
which are answered by 13 “yes” or
“no” forced-choice questions. The Hong
Kong Questionnaire [11] was developed
three years later and comprises 13 ques-
tions assessing symptoms which have
arisen during the patient’s lifetime, as
well as the frequency of these symptoms
during the past year. The latter ques-
tionnaire also features a “don’t know”
option. The Mayo Sleep Questionnaire
[12, 13] is not exclusively dedicated to
RBD, but does include an introductory
RBD question, which, if positive, leads
on to further questions. The Innsbruck
RBD Inventory [14] is a simple ques-
tionnaire containing only ﬁve speciﬁc
RBD questions, which can be answered
with “don’t know” as well as with “yes”
or “no”.
In addition, two single questions have
been developed for RBD screening pur-
poses. The ﬁrst of these is RBD1Q, pub-
lished by Ron Postuma and International
RBD Study Group authors [15]. The sin-
gle question is as follows: “Have you
ever been told, or suspected yourself, that
you seem to ‘act out your dreams’ while
asleep (for example, punching, ﬂailing
your arms in the air, making running
movements, etc.)?” The Innsbruck RBD
Inventory also includes a single question
for screening for RBD: “Do you kick or
hit during your sleep because you dream
that you have to defend yourself?” [14].
All of the aforementioned questionnaires
have been validated and demonstrated
acceptable sensitivity and speciﬁcity in
the validation studies [16].
Nevertheless, recent experiences have
shown that uncritical use of question-
naires can lead to false-negative and false-
positive results, particularly if patients
complete themaloneandwithoutthehelp
of a trained interview partner: a striking
observation was that healthy individuals,
with no indications of RBD in a subse-
quent sleep interview and PSG exami-
nation, scored 16% false-positive on the
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Tab. 1 Deﬁnitionofphasic, tonic, and“any”EMGactivityduringREMsleepaccording to theSIN-
BAR criteria [30]
EMG activity in REM sleep
Phasic Short burst of EMG activity lasting between 0.1 and 5 s, which is more than twice as
high as the background EMG amplitude. Can be measured in 3-s mini-epochs or 30-s
epochs
Tonic EMG tone increased by at least a factor of two or four compared to baseline in more
than half of the epoch, i.e. ≥ 10 s in 20-s epoch or ≥ 15 s in 30-s epoch.
“Any” Either phasic or tonic EMG activity. In addition, tonic and phasic muscle activity
lasting between 5 and 15 s can be scored. Can be measured in 3-s mini-epochs or
30-s epochs
EMG electromyography, REM rapid eye movement
RBD Inventory [17]. It has also been
revealed that the prevalence of probable
RBD in population studies varies when
several questionnaires are used in par-
allel [18]. Also, among PD patients, the
number of diagnoses correctly identiﬁed
using questionnaires diﬀers widely from
subsequent PSG, depending on the set-
tings under which the questionnaire was
applied [19].
What role does video play in the
diagnosis of RBD?
During the past decade, numerous au-
thors have concerned themselves with
the analysis of video recordings of RBD
patients. Video analysis methods ranged
from description only to a severity clas-
siﬁcation [20]. To the best of our know-
ledge, theﬁrst studyonthis topicwasper-
formed by Emilia Sforza in 1988 [21].
Over the past 10 years, our group has
also worked on video classiﬁcation of
motor events in RBD patients [22–24].
We were able to show that even among
patients with severe RBD, the major-
ity of motor events are “very small el-
ementary movements.” The far better-
known dramatic, “violent” behaviors are
comparatively rare, even in severe RBD,
and should as such be interpreted as
the proverbial “tip of the iceberg.” Fur-
thermore, we were able to demonstrate
that the majority of elaborate and vi-
olent motor events were initiated dur-
ing REM sleep with rapid eye move-
ments (in contrast to REM sleep without
rapid eye movement), such that one can
speak of a gating function of REM sleep
with rapid eye movements. Simple my-
oclonic background jerking is, however,
observed during the entire phase of REM
sleep.
In contrast to the very elaborate ap-
proachofdescriptive, videography-based
characterization of RBD events, Sixel-
Döring and Trenkwalder have developed
a very simple severity scale for clinical
routine [25]. Using this scale, motor
events are classiﬁed from 0 to 3 (0: REM
onlywithout atonia, 1: small distalmove-
ments, 2: proximal muscle involvement,
3: with axial movements; vocalization is
classiﬁed as “1” present or “0” absent).
Thesameworkinggroupalsoshowedthat
in newly diagnosed, as-yet-untreated PD
patients without RBD, very small mo-
tor events (REM sleep behavioral events,
RBE) possibly precede the diagnosis of
full-blown RBD, and could thus perhaps




While video analyses depend on the oc-
currence of unpredictable, perhaps rare
events, polysomnographic EMG analysis
has theadvantage thatREMsleepwithout
atonia exhibits very high night-to-night
stability. Several studies have demon-
strated that even a single polysomnog-
raphy night is adequate (providing REM
sleep is present) for diagnosis of RBD
[27, 28]. Moreover, polysomnography
also has the advantage that the investiga-
tor can select which muscle channels are
registered in addition to the EEG, EOG,
and cardiorespiratory channels. The se-
lection ranges from the classic PSGmus-
cles (mental, submental, and tibialis ante-
rior muscles) to numerous other muscles
of the upper and lower extremities, prox-
imal and distal, agonists and antagonists,
as well as muscles of the trunk or other
muscles served by cranial nerves [29, 30].
The characteristic ﬁnding in RBD pa-
tients is increased muscle activity during
REM sleep, which is frequently imme-
diately recognizable, particularly when
enough EMG channels are registered.
Thecurrentscoringmethodsarebasedon
diﬀerentiation between tonic and phasic
muscle activity, as originally described by
Lapierre and Montplaisir [31]. Various
other designations and additional crite-
ria have, however, been proposed (see
[20] for a review). The Sleep Innsbruck
Barcelona (SINBAR) group performed
multiple investigations aimed at deter-
mining which minimal combination of
EMG channels/muscle registrations per-
mitted reliable diagnosis of RBD. Follow-
ing several initial studies [29, 32], it was
also possible to publish normative values
for the ﬁrst time, above which detected
tonic and phasic muscle activity (deﬁned
in . Tab. 1 and presented exemplarily in
. Fig. 1 and2) canbe viewed asRBD, pro-
vided the other diagnostic criteria, i. e.,
clinical or videographic criteria, are ful-
ﬁlled. The latter study also demonstrated
that chinmuscle registrations forRBDdi-
agnosis are especiallywell complemented
by registrationof the ﬂexor digitorum su-
perﬁcialis muscle in the forearm, since
muscle activity during REM sleep in this
region is particularly speciﬁc to RBD. In
contrast, the frequently registered tibialis
anterior muscle is signiﬁcantly less spe-
ciﬁc, particularly in light of the fact that
patients in the second half of their lives
frequently also exhibit pathological mus-
cle activity during REM sleep in this area
due to other factors, e. g., neuropathies
or radicular lesions. Additionally, it was
observed that tonic EMG activity, which
is only measured on the chin, and pha-
sic muscle activity can be meaningfully
extended by an “any” EMG activity cate-
gory: based on the previous diﬀerentia-
tion, all muscle activities lasting between
5 and 15 s (with 30-s epochs), i. e., every-
thing which did not correspond to the
criteria for tonic (>15s)orphasic (0.1-5 s)
activity, was not counted. It is important
to note that EMG analysis usually takes
place in 3-s mini-epochs. This means
that, for example, a phasic switch in one
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outof tenmini-epochswouldcorrespond
to 10% RWA-positive mini-epochs. Us-
ing this method it could be shown that,
compared to controls, far more EMG ac-
tivity was found in RBD in every single
one of the 13 striated muscles investi-
gated (cranial nerve supplied, upper and
lower extremities [30]), although com-
bination of the mentalis and the ﬂexor
digitorum superﬁcialismuscles proﬀered
the best sensitivity and speciﬁcity with
minimal registration channels. Where
RBD is suspected it is therefore recom-
mended – and this is in agreement with
recommendations made by Mahowald
and Schenck 30 years ago [33] – that
the upper extremities also be registered
during polysomnography. By applying
the SINBAR methods [30], cutoﬀ values
could also be published for the ﬁrst time
(for thechin3-smini-epochs: “any”EMG
activity at 18%; for the combination of
chin and ﬂexor digitorum superﬁcialis:
the cutoﬀ value was 32% based on en-
tire REM sleep for the 3-s mini-epochs,
and 27% for 30-s epochs according to
a simpliﬁed analysis based on American
Academy of Sleep Medicine recommen-
dations). Similar normative values have
since been published by the Rochester
group [34].
The disadvantage of manually quanti-
fying EMG activity during polysomnog-
raphy is that it is hugely time intensive
and places high technical demands on
the scorer for this type of analysis. For
this reason, many investigations aimed at
achieving computer-assisted quantiﬁca-
tion of EMG activity during REM sleep
have been carried out during the past
10 years. The earliest attemptsweremade
in theUSA; later on, programs fromGer-
many, Denmark, Italy, and Austria were
also validated [16]. These programs were
based on very diﬀerent algorithms. The
algorithm used in our clinic is based on
an algorithm built into the PSG system,
whichenablestonicandphasicmuscleac-
tivity in the chin and the ﬂexor digitorum
superﬁcialis (as well as in other, freely
programmable muscles) to be precisely
quantiﬁed according to the well-deﬁned
criteria “tonic”, “phasic”, and “any”. This
method has been validated and demon-
strated excellent results [35]. One of
the better-known analysis methods is the
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Abstract
Background. REM sleep behavior disorder
(RBD) is parasomnia characterized by dream
enactment and enabled by disruption of
physiologicalmuscle atonia during REM sleep.
Over the past few years, diagnostic criteria
and the methods used to conﬁrm diagnosis
have been updated.
Objective. In this review article, the current
knowledge regarding RBD diagnosis and
treatment is presented.
Methods. A selective literature search was
carried out.
Results and discussion. Although several
RBD screening questionnaires have been
developed, diagnosis can only be deﬁnitely
conﬁrmed on the basis of polysomnography.
New methods for scoring electromyography
(EMG) activity during REM sleep have
been proposed during recent years and
cutoﬀ values have been established. The
latest cutoﬀ values for scoring EMG activity
during REM sleep are included in the
International Classiﬁcation of Sleep Disorders
(ICSD). The cutoﬀ of 27% muscle activity
during REM sleep suggested by the Sleep
Innsbruck Barcelona (SINBAR) group was
also included in the third edition of the ICSD.
The best-researched treatments for RBD are
clonazepam andmelatonin.
Keywords
Parasomnias · Violent dream · REM sleep ·
Polysomnography · SINBAR




störung (REM Sleep Behavior Disorder, RBD)
ist eine Parasomnie, die durch Ausagieren
von Träumen gekennzeichnet ist und
durch eine Störung der physiologischen
Muskelatonie des REM-Schlafs ermöglicht
wird. In den letzten Jahren wurden die
diagnostischen Kriterien und die Methoden
zur Diagnosestellung aktualisiert.
Ziel der Arbeit. In diesem Übersichtsartikel
werden die derzeitigen Erkenntnisse zur
Diagnose und Therapie vorgestellt.
Methode. Es wurde eine selektive
Literaturrecherche durchgeführt.
Ergebnisse und Diskussion. Obwohl mehrere
Fragebögen zum Screening für RBD entwi-
ckelt wurden, kann eine sichere Diagnose
nur anhand einer Polysomnographie gestellt
werden. Neue Methoden zur Auswertung der
EMG-Aktivität im REM-Schlaf wurden in den
letzten Jahren vorgeschlagen und Cut-oﬀ-
Werte wurden etabliert. In die International
Classiﬁcation of Sleep Disorders sind die
neuesten Cut-oﬀ-Werte für Scoring von EMG-
Aktivität im REM-Schlaf eingegangen. Der
von der SINBAR (Sleep INnsbruck BARcelona)-
Gruppe vorgeschlagene Cut-oﬀ von 27%
Muskelaktivität im REM-Schlaf ist auch in
die ICSD-3 übernommen worden. Die am
besten untersuchten Therapien bei RBD sind
Clonazepam und Melatonin.
Schlüsselwörter
Parasomnien · Gewalt im Traum · REM-Schlaf ·
Polysomnographie · SINBAR
REM atonia index, which was developed
by Raﬀaele Ferri and considers only the
activity of the chin musculature. The lat-
ter analysis requires an additional pro-
gram [36, 37].
Despite the promise of simple indices
and computer-assisted quantiﬁcation
methods for REM sleep without atonia,
solid analysis of the raw data with precise
elimination of artefacts is essential to
avoid false positives (e. g., false-positive
RWA classiﬁcation in patients with snor-
ingormovementartefacts accompanying
respiratory events) [35].
RBD as an early indicator of
neurodegenerative disease
Studies on RBD as an early indicator of
neurodegenerative disease published in
the 1990s and early 2000s reached the
conclusion that approximately 40–50 %
Somnologie · Suppl 1 · 2017 S3
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Fig. 18 30-s epoch of REM sleep,with REM sleepwithout atonia in the sevenmuscle channels between EEG and ECG
of RBD patients would develop a neu-
rodegenerative disease, primarily a synu-
cleinopathy, a good 10 years later [38,
39]. In 2009, the 12-year risk was re-
ported to be 52.4 % [40]. However, cur-
rent studies have demonstrated that the
rate of conversion to a synucleinopathy
is much higher, at 81% [41, 42]. In
light of this high conversion rate and
the long time interval between diagno-
sis of RBD and conversion, the ques-
tion obviously arises of whether other
biomarkers exist, ones which are able to
indicate an increased risk of conversion
in the near future. This predictive prop-
erty has been investigated for numer-
ous risk markers (particularly anosmia/
hyposmia, autonomic dysfunction, neu-
ropsychologic tests, colordiscrimination,
andquantitativemotortests). Thesestud-
ies showed, for example, that in patients
with RBD still classiﬁed as idiopathic,
the coexistence of olfactory disturbance
or color vision impairment was associ-
ated with an increased risk of conversion
to a neurodegenerative disease [43, 44]
Although one thinks primarily of
polysomnography for RBD, 1.5 Tesla
DTI and VBMMRI also enable excellent
discrimination between RBD subjects
and controls: in 26 RBD patients and
14 controls, Scherﬂer and colleagues
were able to show that reductions in
fractional anisotropy were found in areas
such as the periaqueductal grey matter
and the lateral pontine tegmentum in
RBD patients. Additionally, increased
mean diﬀusivity was observed in RBD
patients in areas which could corre-
spond to the sublaterodorsal nucleus,
the pedunculopontine nucleus, and the
locus coeruleus, as well as in areas im-
portant for regulation of muscle tone
during REM sleep [45]. Further imaging
studies were performed by numerous
groups using diﬀerent methods, some of
which revealed involvement of yet other
areas [46–48]. Using FP-CIT SPECT
and transcranial sonography, it was pos-
sible to show – with 100% sensitivity –
that among 43 RBD patients, those in-
dividuals who already had an abnormal
baseline ﬁnding in one of the methods
converted to a neurodegenerative dis-
ease within 2.5 years [49]. Furthermore,
a dopamine transporter follow-up study
using putamen and caudate measure-
ments also showed that patients who
converted had lower baselines and an
increased decline in uptake [50].
New results from long-term
studies on surrogate markers of
neurodegenerative disease
Mahlknecht and colleagues evaluated
IRBD patients using complete Sniﬃn’
Sticks tests, and were able to show that
olfactory function could predict con-
version into Lewy body disease [43].
Recently, the same group showed that
a subscore of the top 8 discriminating
odors was as good as the whole Sniﬃn’
Sticks test [51]. On the other hand, the
SINBAR group was able to demonstrate
that sonographicallydeterminedchanges
in the substantia nigra are unsuitable for
monitoring the process of neurodegen-
erative disease, since these are stable over
theyears [52]. A joint investigationby the
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Fig. 28 Phasic and tonic EMGactivity in one epoch of REM sleep in RBDpatients
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International RBD Study Group revealed
an unexpected association with lifetime
use of antidepressants in patients with
IRBD, an eﬀect thatwas stronger than the
association with depression alone. Fur-
thermore, an association with ischemic
heart disease was also observed [53].
In a four-year follow-up investigation,
the International RBD Study Group eva-
luated 279 RBD patients from 12 centers
who had initially participated in a ques-
tionnaire study. Patients who converted
were older. Neither caﬀeine, nor smok-
ing, nor alcohol exposure was able to
predict conversion. Unexpectedly, con-
verted patients were less likely to have
beenexposedtopesticidesandweremore
likely to have a family history of demen-
tia. Motor and autonomic symptoms
were also more frequently observed in
convertedpatients, andamongconverted
patients with dementia, clonazepam use
was more frequent [54].
Therapy
The best-investigated substances used to
treat RBD are clonazepam and mela-
tonin. Numerous larger series andcohort
studies have demonstrated good eﬃcacy
of clonazepam 0.5–2 mg [55]. Mela-
tonin 3–9 mg has also been tested many
times openly, as well as in one much
smaller study with a double-blind design
[56]. Large multicenter, double-blind,
placebo-controlled studies with well-de-
ﬁned outcomes are urgently needed.
Earlier case studies addressing treat-
mentofREMsleepdisorder alsomention
many other substances, although the sig-
niﬁcanceandvalidityof these case studies
is often questionable – not only due to
theiropennatureandtheverysmallnum-
ber of cases considered, but also in light
of the sometimes disputable RBD diag-
nosis (particularly where PSG is lacking
and the clinical symptoms described are
atypical).
Do RBD patients really dream
diﬀerently?
Even early studies indicated that PD pa-
tientsonlevodopatreatmentexhibitedal-
tered dream content, although RBD had
not yet been deﬁned at this time [57].
Classically, RBD dreams are described
asbeingparticularly“action-packed”, and
often involveﬁghtorﬂight, attacks, or an-
imals [58]. By reading the dream report
aloud and subsequently playing diﬀer-
ent video clips, an earlier study was able
to show, with statistical signiﬁcance, that
independent observers canmatch the be-
haviors observed in RBD patients to par-
ticular portions of the dream better than
chance [59]. Recently, Katja Valli was
also able to demonstrate that the dreams
of PD patients with RBD did not diﬀer
greatly from PD patients without RBD
when woken directly from REM sleep
[60].
Practical conclusion
4 Suspicion of REM sleep behavior
disorder can be diagnosed based
on medical history and clinical
presentation. Questionnaires can
be used as a screening method.
Deﬁnitive diagnosis can only be
established using polysomnography.
4 Video-polysomnography demon-
strates that “violent” behavior is
rare, even in severe RBD. The major-
ity of motor events are very small
elementary movements.
4 The advantage of EMG analysis
during polysomnography is that
increased muscle activity during REM
sleep (REM sleep without atonia),
which is characteristic of RBD, has
a very high night-to-night stability.
4 Speciﬁc suitable muscle registrations
and cutoﬀ values are available for
RBD diagnosis. Recording of forearm
FDSmuscle is much recommended in
addition to the tibialis anterior and
mentalis muscles. If EMG activity is
approximately 1/3 of REM sleep this
is in line with RBD.
4 Clonazepam and melatonin are the
best-investigated therapeutic agents.
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